Dr. Yao, Dr. Vijayvergia discuss 2021 ASCO presentation results and the future of NETs North American Neuroendocrine Tumor Society 18:13 3 years ago 4 Далее Скачать
1. NETs Overview, James Yao, MD; MD Anderson, 2018 Houston Conference NETRF 37:26 6 years ago 1 158 Далее Скачать
ASCO 2024: key updates in gastric, colorectal, and hepatocellular cancer treatments VJOncology 0:40 7 months ago 1 440 Далее Скачать
Dr. Yao Discusses Unanswered Questions Regarding the Treatment of Pancreatic NETs Targeted Oncology 0:52 10 years ago 100 Далее Скачать
Expert Video Report on immunotherapy in gastro oesophageal cancer from 2021 ASCO Annual Meeting European Society for Medical Oncology (ESMO) 11:12 3 years ago 1 362 Далее Скачать
Dr. Yao on the RADIANT-4 Study for NETs of Lung or GI Origin OncLive 2:07 9 years ago 409 Далее Скачать
Dr. Yao on the Use of Octreotide in Elderly Patients With NET OncLive 1:35 11 years ago 1 976 Далее Скачать
ASCO President Dr Yu Discusses Aggregating Patient, Doctor Data AJMCtv 2:37 10 years ago 68 Далее Скачать
Dr. Yelena Janjigian on the MATTERHORN Study: Durvalumab Plus FLOT in Gastric Cancer at ASCO GI 2024 GI Oncology Now 5:18 11 months ago 295 Далее Скачать
Dr. Yao on Health-Related QOL in Patients With Neuroendocrine Tumors OncLive 1:52 8 years ago 165 Далее Скачать
Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors Targeted Oncology 2:14 11 years ago 218 Далее Скачать
Neoadjuvant Therapy for RCC from ASCO GU 2017: A Review PracticeUpdate 2:43 3 years ago 23 Далее Скачать
Bladder cancer at ASCO 2022: RC48 vedotin, chemoimmunotherapy VJOncology 1:21 2 years ago 159 Далее Скачать
Dr. James Yao Discusses the Investigation of Biomarkers in Neuroendocrine Tumors Targeted Oncology 1:36 11 years ago 186 Далее Скачать
